Statistical planning in confirmatory clinical trials with multiple treatment groups, multiple visits, and multiple...

Area of Science:

• Biostatistics
• Clinical Trial Design
• Pharmaceutical Research

Background:

• Confirmatory clinical trials often involve multiple primary endpoints, dose groups, and post-baseline visits, creating complex multiplicity challenges.
• Traditional multiplicity approaches may prioritize higher doses, potentially reducing power for lower doses, especially when safety concerns arise for higher doses.

Purpose of the Study:

• To develop and evaluate statistical strategies for managing complex multiplicity in confirmatory clinical trials.
• To address situations where dose-response hierarchies are not fully established or where higher doses have safety concerns.

Main Methods:

• Discusses closed testing procedures utilizing multi-way averages of comparisons.
• Employs illustrative case analyses and simulation studies to evaluate proposed strategies.
• Compares new methods against traditional fixed sequential and Hochberg approaches.

Main Results:

• Proposed closed testing procedures manage multiple doses and endpoints with equal priority.
• These strategies maintain reasonably high statistical power for detecting treatment effects across multiple dimensions.
• The methods provide a flexible framework for complex multiplicity scenarios.

Conclusions:

• Closed testing procedures based on multi-way averages offer an effective solution for complex multiplicity in clinical trials.
• These strategies balance the evaluation of different doses and multiple endpoints, enhancing overall study power.
• The findings support the adoption of these advanced statistical methods for robust clinical trial design.